Skip to content
nurses.jpg
  1. Home/
  2. Our commitment to healthcare professionals

Our commitment to healthcare professionals

Johnson & Johnson is committed to helping educate healthcare professionals (HCPs) at the pace of innovation.

We deliver a wide spectrum of hands-on learning, virtual reality and digitized professional education to hundreds of thousands of HCPs globally each year through the Johnson & Johnson Institute.

From continuing medical education and fellowship programs to leadership resources and nursing initiatives, Johnson & Johnson is helping HCPs keep pace with today’s complex and rapidly changing healthcare environment to improve health for all.

Expand
Smart manufacturing fuels our ability to bring these innovations forward with urgency. Digital twins simulate steps in our supply chain and AI-driven predictions help us anticipate when and where our medical products are needed.

By combining deep understanding of technology and science with our people’s determination, we power the future of human health.
Collapse

Innovating in health and care

The surgical devices I design for Johnson & Johnson can help make medical procedures more efficient for surgeons and safer for patients

Candice Otrembiak’s work combines her love of science with her natural problem-solving skills. The result: high-tech devices that help make medical procedures more efficient for surgeons and safer for patients.

6 ways J&J is using AI to help advance healthcare including equipping HCPs with insights, improving surgical training and procedures and more

Artificial intelligence is revolutionizing healthcare—from improving surgical training and procedures to equipping healthcare providers with insights and personalizing care for patients around the world. See how the company is harnessing its extraordinary power.

Our history of advocating for, elevating and empowering nurses

In alignment with a long-standing commitment to supporting frontline health workers, Johnson & Johnson is proud to continue our legacy with the nursing profession by working with our partners to attract and strengthen an innovative, thriving and diverse nursing workforce, empowered to advance health equity and transform healthcare.

How Johnson & Johnson is working to get medications to people around the world who need them most

In the just-released 2024 Access to Medicine Index, the company ranks among the top 5 improving access to medicines.

Bringing orthopaedic surgical care closer to home for Malawi’s rural population

With timely surgical care, most long bone fractures can be easily repaired. Five new state-of-the-art operating rooms are making it possible for more patients in Malawi to recover quickly from their injuries.

An eye for innovation: helping surgeons see more during spinal operations

With a unique disposable camera the size of a pinkie finger, Eric Buehlmann and his team pioneered a better—and easier—way for doctors to perform back procedures.

Meet a nurse who leads clinical trials to find innovative cancer therapies

Melissa Martinez is a clinical scientist within Johnson & Johnson’s Interventional Oncology R&D group. Not only is she helping to develop lifesaving treatments, she’s redefining what it means to pursue a career in nursing.

Terra Kremer, Ph.D., is on a mission to create self-sterilizing surgical tools

Since its launch, Johnson & Johnson has focused on helping make surgeries safer. Learn how this analytical microbiologist and her team are continuing in that tradition with a digital app that aims to change the way medical devices are designed and sterilized.

More from Johnson & Johnson

Johnson & Johnson named to Fortune’s 2025 America’s Most Innovative Companies list

The company’s commitment to developing solutions that tackle the world’s most pressing health challenges has helped Johnson & Johnson be recognized as the top-ranked healthcare company on the list.

Inside Johnson & Johnson’s decades-long quest to develop effective treatments for IBD

Inflammatory bowel disease doesn’t have a cure—yet. But the recent FDA approval of a promising medication is the latest in a long line of treatments from Johnson & Johnson that are helping patients with IBD.